Evaluation status available after sign-in
About the journal
Diabetes, Metabolic Syndrome and Obesity is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 4,320 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1178-7007
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,320 USD
- Articles in DOAJ
- 3349
- Declared review time
- 16 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2009-04-23
- PUBMED · 2008-06-19
- Indexing
- DOAJ · PUBMED
- APC
- 4,320 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
3349
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
3482
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
97
i10-index
1603
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2009-04-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 75%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Diabetes, metabolic syndrome and obesity, targets and therapy
- Source type
- journal
- NLM unique ID (PubMed)
- 101515585
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine
LCC codes
RC581-951
Subject areas
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Adipokines, Inflammation, and Metabolic Diseases
Show all subjects (75)
- Chronic Kidney Disease and Diabetes
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Diabetes Management and Education
- Diabetes Management and Research
- Diabetes Management and Research
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Diabetes Management and Education
- Diabetes Management and Education
- Chronic Kidney Disease and Diabetes
- Chronic Kidney Disease and Diabetes
- Obesity, Physical Activity, Diet
- Bariatric Surgery and Outcomes
- Bariatric Surgery and Outcomes
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- Diet and metabolism studies
- Diet and metabolism studies
- Diabetes and associated disorders
- Diabetes and associated disorders
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Pharmacology and Obesity Treatment
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Natural Antidiabetic Agents Studies
- Pancreatic function and diabetes
- Cardiovascular Disease and Adiposity
- Cardiovascular Disease and Adiposity
- Diabetes and associated disorders
- Diet, Metabolism, and Disease
- Gestational Diabetes Research and Management
- Diet, Metabolism, and Disease
- Gestational Diabetes Research and Management
- Gestational Diabetes Research and Management
- Retinal Diseases and Treatments
- Bariatric Surgery and Outcomes
- Diet, Metabolism, and Disease
- Diabetic Foot Ulcer Assessment and Management
- Diabetic Foot Ulcer Assessment and Management
- Diabetic Foot Ulcer Assessment and Management
- Obesity, Physical Activity, Diet
- Obesity, Physical Activity, Diet
- Nutrition and Health in Aging
- Nutrition and Health in Aging
- Retinal Diseases and Treatments
- Adipose Tissue and Metabolism
- Retinal Diseases and Treatments
- Adipose Tissue and Metabolism
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Pharmacology and Obesity Treatment
- Pharmacology and Obesity Treatment
- Gout, Hyperuricemia, Uric Acid
- Gout, Hyperuricemia, Uric Acid
- Chronic Disease Management Strategies
- Chronic Disease Management Strategies
- Body Composition Measurement Techniques
- Renal Diseases and Glomerulopathies
- Genetic Associations and Epidemiology
- Regulation of Appetite and Obesity
- Gut microbiota and health
- Adipose Tissue and Metabolism
- Acute Kidney Injury Research
Keywords (DOAJ)
- diabetes
- obesity
- metabolic syndrome
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ